Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease

The American Journal of Cardiology

Volumn 76, Issue 1-2 SUPPL. 1, 1995, Pages

  Eichstädt, Hermann W ^a   Eskötter, Herbert ^b   Hoffmann, Ingo ^a   Amthauer, Holger W ^a   Weidinger, Gottfried ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Clinical Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THALLIUM 201; TRIACYLGLYCEROL;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE TEST; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; CORONARY CIRCULATION; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; EXERCISE TEST; FATTY ACIDS, MONOUNSATURATED; FEMALE; HEART RATE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INDOLES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATION;

EID: 0029007253     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(05)80033-5     Document Type: Article

References (16)

1. Endothelial function in human coronary arteries in vivo; focus on hypercholesterolemia
2. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress
3. Correction of endothelial dysfunction tion in coronary microcirculation of hypercholesterolaemic patients by l-arginine
4. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
5. Computer-assisted evaluation of ischemic defects in the 201-thallium myocardial scintigraphy
6. Can lifestyle changes reverse coronary heart disease?
7. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
8. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
9. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A four-year follow-up
10. Effects of therapy with cholestyramine on progression of coronary atherosclerosis: results of the NHLBI type II coronary intervention study
11. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS)
12. Lipid lowering and plaque regression; new insights into prevention of plaque disruption and clinical events in coronary disease
13. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
14. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.
15. Atherosclerosis of lipoprotein-induced endothelial dysfunction; potential mechanisms underlying reduction in EDRF/nitric oxide activity
16. Is endothelial dysfunction reversible?